ICH
ICH Q10 1.2
Scope
1. PHARMACEUTICAL QUALITY SYSTEM
Section text
This guideline applies to the systems supporting the development and manufacture of pharmaceutical drug substances (i.e., API) and drug products, including biotechnology and biological products, throughout the product lifecycle.
The elements of ICH Q10 should be applied in a manner that is appropriate and proportionate to each of the product lifecycle stages, recognising the differences among, and the different goals of each stage (see Section 3).
For the purposes of this guideline, the product lifecycle includes the following technical activities for new and existing products:
• Pharmaceutical Development:
o Drug substance development;
o Formulation development (including container/closure system);
o Manufacture of investigational products;
o Delivery system development (where relevant);
o Manufacturing process development and scale-up;
o Analytical method development.
• Technology Transfer:
o New product transfers during Development through Manufacturing;
o Transfers within or between manufacturing and testing sites for marketed products.
• Commercial Manufacturing:
o Acquisition and control of materials;
o Provision of facilities, utilities, and equipment;
o Production (including packaging and labelling);
o Quality control and assurance;
o Release;
o Storage;
o Distribution (excluding wholesaler activities).
• Product Discontinuation:
o Retention of documentation;
o Sample retention;
o Continued product assessment and reporting.
Source: International Council for Harmonisation (ICH) · © ICH. Per the legal notice in each guideline, the document may be used, reproduced and distributed provided ICH's copyright is acknowledged; any adaptation or translation must be labelled as such and must not imply ICH endorsement. · retrieved 2026-11-15